So far, the studies on CP novel formulations are mostly on psoriasis treatment, but a few have revealed that the formulations have prospective uses for the management of other chronic skin ailments including eczema, vitiligo, contact dermatitis recurrent aphthous stomatitis, and oral lichen planus. The gene discussed is CP; the disease is contact dermatitis.